Calcium and magnesium levels during automated plateletpheresis in normal donors

Transfusion Medicine

Volumn 15, Issue 3, 2005, Pages 233-236

  Das, S S ^a   Chaudhary, R ^a   Khetan, D ^a   Shukla, J S ^a   Agarwal, P ^a   Mishra, R B ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Blood donor; Electrolytes; Plateletpheresis

Indexed keywords

CALCIUM ION; MAGNESIUM ION;

ADULT; ARTICLE; BLOOD DONOR; CELL SEPARATION; CHELATION; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; HYPOCALCEMIA; HYPOMAGNESEMIA; MALE; NORMAL HUMAN; PROPHYLAXIS; THROMBOCYTOPHERESIS;

BLOOD DONORS; CALCIUM; HUMANS; HYPOCALCEMIA; MAGNESIUM; PLATELETPHERESIS;

EID: 20444444309     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2005.00576.x     Document Type: Article

References (13)

1. Bennett, M.W., Webster, N.R. & Sadek, S.A. (1993) Alteration in plasma magnesium concentration during liver transplantation. Transplantation, 56, 859-861.
2. Boogaerts, M.A. (1987) Side effects of hemapheresis. Transfusion Medical Review, 1, 186-194.
3. Elin, R.J. (1994) Magnesium: the fifth but forgotten electrolyte. American Journal of Clinical Pathology, 102, 616-622.
4. Farrokhi, P., Farahmand, H., Bismuth, A., Suarez, C., Ducot, B., Gillon, M.C., Debat, P., Laskowski, P. & Pinon, F. (1998) How to stabilize the level of ionized calcium and citrate during plateletpheresis. Vox Sanguinis, 74, 7-12.
5. Galaser, A., Zimmermann, R., Zingsem, J., Weisbach, V., Neidhardt, B. & Eckstein, R. (1999) Veranderung der Spenderausschlußrate bei der Gewinnung von Apheresespendern durch die NeufaSsung der 'Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (hamotherapie)'. Infusionsther Transfusionsmed, 26, 300-305.
6. Kulkarni, P., Bhattacharya, S. & Petros, A.J. (1992) Torsade de pointes and long QT syndrome following major blood transfusion. Anesthesia, 47, 125-127.
7. Laspina, S.J., Browne, M.A., McSweeney, E.N., Lawlor, J., Whelan, D.M., Kinsella, A.L. & Murphy, W.G. (2002) QTc prolongation in apheresis platelet donors. Transfusion, 42, 899-903.
8. McLeod, B.C., Price, T.H., Owen, H., Ciavarella, D., Sniecinski, I., Randels, M.J. & Smith, J.W. (1998) Frequency of immediate adverse effects associated with apheresis donation. Transfusion, 38, 937-943.
9. Mercan, D., Bastin, G., Lambermont, M. & Dupont, E. (1997) Importance of ionized magnesium measurement for monitoring of citrate anticoagulated plateletpheresis. Transfusion, 37, 418-422.
10. Rebeyka, I., Yeh, T. Jr, Hanan, S.A., Borges, M.R., Lee, K.F., Tuchy, G.E., Abd-Elfattah, A.S. & Wechler, A.S. (1990) Altered contractile response in neonatal myocardium to citrate-phosphate-dextrose infusion. Circulation, 82 (5 Suppl.), IV367-IV370.
11. Rude, R. (1995) Magnesium metabolism In: Principles and Practice of Endocrinology and Metabolism (2nd edn) (ed. Becker, K.L), 616-622. JB Lippincott, Philadelphia.
12. Toffaletti, J., Nissenson, R., Endres, D., McGarry, E. & Mongolien, G. (1985) Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium component, and other electrolytes in normal adult during plateletpheresis. Journal of Clinical Endocrinological Metabolism, 60, 874-879.
13. Walser, M. (1961) Ion association. V. Dissociation constant for complexes of citrate with sodium, potassium, calcium and magnesium ions. Journal of Physical Chemistry, 65, 159-161.